The president-elect’s office has raised concerns regarding the import of medicines and medical consumables from India through an agreement between STO and a Tamil Nadu-based company. Mohammed Firzul Abdullah Haleel, spokesperson for President-elect Dr. Mohamed Muizzu, held a press conference to discuss the health sector’s challenges highlighted by transitional committees.
Haleel emphasized the importance of addressing the issues faced by the healthcare sector, pointing out that some hospitals and health centers are struggling with depleting stocks of essential items. He expressed concerns about the timing of the deal, considering it a sensitive issue related to essential public services. Haleel’s comments came in the context of the transitional committee’s efforts to assess government agencies and identify challenges within the health sector.
The president-elect’s office’s concerns arise amid a backdrop of assurance from the government that healthcare services will continue without interruption, despite calls for a temporary halt in supplies from India. Furthermore, the global spotlight has turned toward Indian pharmacies due to concerns over specific medications that have had adverse effects, particularly in children.
